Although elevated expression of ABCG2 or ENPP1 was not correlated with recurrence of breast cancer, co-expression of ABCG2 and ENPP1 was moderately associated with poor prognosis (HR=1.84; P=0.062; Fig. 9c). Here, ENPP1 is linked to breast carcinoma.